Richard A. Edlin
CIK 1699676 · last filed 2023-03-09
Richard A. Edlin is a corporate insider who has filed 9 SEC Form 4 insider transactions across 1 company since 2017. The most recent filing, for EGRX, was dated Mar 9, 2023. Across all open-market trades the lifetime net is +$265.9K, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
9
$265.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Director | 22,600 | $2.14 | $48.4K | $265.9K | 9 | 2023-03-09 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-08 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Sell (S) | −6,800 | -$210.7K | EDGAR |
| 2022-03-02 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-04 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-07 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-25 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-22 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Buy (P) | +6,000 | $476.6K | EDGAR |
| 2017-03-21 | EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Grant (A) | — | $0 | EDGAR |